Amgen articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2013/06/18 22:17
2013/06/18 22:17
20h
Scientists Catch EGFR Passing a Crucial Message t...
Newswise — HOUSTON ¬¬– Researchers have discovered and mapped the signaling network between two previously unconnected proteins, exposing a link that, if broken, could cut off cancer cell growth at...
2013/06/18 22:17
2013/06/18 22:17
Latest videos
2013/06/18 21:58
2013/06/18 21:58
21h
Traders stay on the sidelines ahead of FOMC
Tue 18 Jun 2013 LONDON (SHARECAST) - - Fed Chairman Bernanke may not opt for another term - Fed policy meeting starts - Multi-family housing starts bounced back less than expected Dow Jones...
Read more at ShareCast, ShareCast
1
RELATED
2013/06/18 20:21
2013/06/18 20:21
22h
N.J. gets $3.75 million in drug fraud settlements
New Jersey will receive $3.75 million as its share in separate multi-state settlements of cases of alleged pharmaceutical fraud, Acting Attorney General John J. Hoffman said Tuesday. Ranbaxy, a...
2013/06/18 15:09
2013/06/18 15:09
1d
Enbrel and the Autoimmune Era
Enbrel is one of the top ten drugs in the U.S. by sales, garnering the pharmaceutical giants who co-market the drug, Amgen and Pfizer, billions of dollars in revenue annually. People take Enbrel for...
2013/06/17 14:31
2013/06/17 14:31
2d
With new talent and leadership, Jelly Belly gets ...
With new talent and leadership, Jelly Belly gets the results MINNEAPOLIS, Minn. — The Jelly Belly-Kenda team has struggled in recent years to attract invites to races like the Amgen Tour of...
2013/06/17 11:56
2013/06/17 11:56
2d
June 17
Overnight Media Digest * The United States and Europe plan to push for nuclear talks with Iran following the surprise victory of centrist Hassan Rohani in presidential elections. * Airbus is on...
Read more at Zero Hedge, Zero Hedge
1
RELATED
2013/06/17 09:25
2013/06/17 09:25
2d
Nanotechnology Drug Delivery Market in the US 201...
Nanotechnology Drug Delivery Market In The Us Expected To Grow At A CAGR Of 84.79 Percent Over The Period 2012-2016 TechNavio's report, the Nanotechnology Drug Delivery Market in the US 2012-2016,...
4
RELATED
Technavio Amgen Celgene Cephalon Elan Corp.
MENTIONED
2013/06/16 16:31
2013/06/16 16:31
3d
J.J. Haedo enjoys fresh approach, mentoring young...
J.J. Haedo enjoys fresh approach, mentoring youngsters in return Stateside MINNEAPOLIS (VN) — J.J. Haedo (Jamis-Hagen Berman) has returned to the U.S. peloton this year after spending six seasons on...
Minneapolis Hagen Berman Toyota Janier Acevedo Amgen
MENTIONED
2013/06/14 22:31
2013/06/14 22:31
4d
Friedman finding his form with NVGP race lead
Friedman finding his form with NVGP race lead Mike Friedman (Optum-Kelly Benefit Strategies) sprinted to second place at the Nature Valley Grand Prix Cannon Falls Road Race Thursday night out of a...
7
RELATED
Casey B. Gibson Mike Friedman Jade Wilcoxson Tibco Tom Zirbel
MENTIONED
2013/06/14 19:21
2013/06/14 19:21
4d
Merck to cut research lab jobs as Perlmutter move...
Bloomberg News Merck & Co., the second-largest U.S. drugmaker, plans to cut jobs at its research laboratories, two months after Roger Perlmutter took helm of the unit. The shakeup includes immediate...
Merck Research Laboratories Merck & Co. WHITEHOUSE STATION Peter Kim Amgen Inc.
MENTIONED
2013/06/14 15:58
2013/06/14 15:58
5d
Stocks drift after slightly mixed data releases
Fri 14 Jun 2013 LONDON (SHARECAST) - - Weaker than expected reading on consumer confidence - Better than forecast current account data - Crude futures move higher, Treasury bond prices up Dow Jones...
2013/06/14 12:27
2013/06/14 12:27
5d
Bankers-Turned-CEOs Fight for Elan in Year’s Bigg...
One worked for Lazard Ltd., the other for Merrill Lynch & Co. One studied industrial engineering at the Universidad Iberoamericana in Mexico, the other politics at Princeton University. Now Pablo...
111
RELATED
Elan Corp. Elan Royalty Pharma NEW YORK Tysabri
MENTIONED
2013/06/14 08:55
2013/06/14 08:55
5d
Xgeva (Denosumab) Approved For Giant Cell Tumor O...
GCTB can become malignant and spread to the lungs, however this is rare. Denosumab is a monoclonal antibody that binds to the protein, RANKL, that is essential for the maintenance of healthy...
1
RELATED
FDA U.S. Food and Drug Administration FDA's Center for Drug Evaluation and Research FDA's Center Richard Pazdur
MENTIONED
2013/06/13 21:57
2013/06/13 21:57
5d
FDA Expands Approval for Amgen Bone Cancer Drug
The Food and Drug Administration has expanded the use of Amgen Inc.’s Xgeva to treat a rare bone cancer, the agency announced Thursday. Xgeva had been approved in 2010 to prevent fractures when...
2013/06/13 19:05
2013/06/13 19:05
6d
FDA OKs expanded use for one of Amgen's best-sell...
The U.S. Food and Drug Administration on Thursday expanded the approved use of Xgeva for treating giant cell tumor of the bone. Xgeva, also known as denosumab, is one of Amgen Inc.’s best-selling...
2013/06/13 16:28
2013/06/13 16:28
6d
NEW YORK, June 13, 2013: Cancer Diagnostics Partn...
The Cancer Diagnostics Partnering Agreements report provides an understanding and access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare...
1
RELATED
2013/06/12 21:19
2013/06/12 21:19
6d
Peel's family health team lauded for use of socia...
PEEL—Peel Public Health has landed top honours for its use of social media. The Canadian Public Health Association (CPHA) announced today that Peel’s family health division is the winner of the 2013...
Facebook Amgen
MENTIONED
2013/06/12 18:56
2013/06/12 18:56
7d
Amgen Expands Licensing Deal for $25 Million
Amgen Inc. announced on Wednesday that it is spending $25 million to expand a licensing agreement with Cytokinetics Inc. to cover the Japanese market. Amgen and the San Francisco company first agreed...
Amgen Inc. San Francisco Astellas Pharma Inc. Tokyo
MENTIONED
2013/06/12 17:32
2013/06/12 17:32
7d
NEW YORK, June 12, 2013: Skin Disease Treatment T...
INTRODUCTIONSTUDY GOALS AND OBJECTIVES The aim of this report is to provide detailed market, technology and industry analyses to help readers quantify and qualify the market for drugs used in the...
2013/06/12 15:39
2013/06/12 15:39
7d
Amgen says ovarian cancer drug meets goal of late...
NEW YORK - Amgen Inc., the world’s largest biotechnology company by sales, said its experimental drug for recurrent ovarian cancer met a late-stage study goal, helping patients live 1.8 months longer...
1
RELATED
Amgen Inc. paclitaxel American Cancer Society NEW YORK
MENTIONED
Parts of this website powered by Open Calais, a toolkit for rich semantic metadata extraction.

Huh, what is this?
Interceder is a topic search engine aggregating the latest news on any topic into a single window of information. This page has been automatically generated. To contact Interceder click here.

Privacy Statement
Your privacy is important. Interceder does not collect and keep any personal information about visitors to the site. Interceder may use third-party advertising companies to serve ads. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements on this website, other websites, and other forms of media about goods and services of interest to you.